- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04246476
Sing for Your Saunter (SFYS)
Sing for Your Saunter: Using Self-generated Rhythmic Cues to Enhance Gait in Parkinson's
Older adults, and particularly those with Parkinson disease (PD), may experience walking difficulties that negatively impact their daily function and quality of life. This project will examine the impact of music and mentally singing on walking performance, with a goal of understanding what types of rhythmic cues are most helpful. Our pilot work suggests that imagined, mental singing (i.e., singing in your head) while while walking helps people walk faster with greater stability, whereas walking to music also helps people walk faster but with reduced stability.
In Aim 1, the investigators will compare walking while mentally singing to walking while listening to music, using personalized cues tailored to each person's walking performance. The investigators hypothesize stride time variability will be less in the mental singing condition compared to listening to music; and that mental singing and listening to music will improve gait speed similarly as compared to the uncued condition. The investigators will also test whether finger tapping, a rhythmic task similar to walking in many ways, responds similarly while mentally singing and listening to music.
In Aim 2, the investigator will investigate the brain mechanisms underlying the enhancements in movement performance seen with mental signing or listening to music. The investigators will use magnetic resonance imaging (MRI) to measure brain activity during finger tapping with and without various cues to understand which areas of the brain are more or less responsive to the cues. The investigators hypothesize individuals with PD will exhibit lesser activation of putamen and greater activation of cortical motor areas and cerebellum compared to controls in all tapping conditions; and internal, mental singing during tapping will elicit greater activation of the putamen and lesser activation of cortical motor areas in both groups compared to uncued tapping and tapping while listening to music.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
During this observational study, all participants will attend two visits 4-10 days apart. At the first visit, all participants (participants with PD and age-matched controls) will wear wearable sensors during the following tasks: walking with no cues; walking while listening to music; and walking while mentally singing. The wearable sensors will measure gait parameters including gait speed and stride time variability. All participants will also conduct the following tasks while finger tapping on a keyboard: tapping with no cues; tapping while listening to music; and tapping while mentally singing.
At the second visit, all participants (participants with PD and age-matched controls) will perform the following tasks during imaging: uncued tapping; listening to music (no tapping); mentally singing (no tapping); listening to music and tapping; and mentally singing and tapping.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Martha Hessler
- Phone Number: 3142861478
- Email: mjhessler@wustl.edu
Study Contact Backup
- Name: Kerri Rawson
- Phone Number: 3142731053
- Email: rawson@wustl.edu
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine Program in Physical Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria for all participants:
- at least 30 years of age;
- willing and able to provide informed consent;
- right-handed or ambidextrous;
- normal hearing;
- weight less than 250 lbs; and
- able to walk for 10 continuous minutes independently.
Inclusion criteria for participants with PD also include:
- diagnosis of idiopathic, typical Parkinson disease according to the United Kingdom Brain Bank Criteria;
- Hoehn & Yahr stages 2-3 (mild to moderate disease severity);
- stable on all PD medications for at least 2 months prior to study entry;
- a score of 1 or less on item # 7 on the New Freezing of Gait Questionnaire; and
- score of ≥ 1 on the Movement Disorder Society - Unified Parkinson Disease Rating Scale (MDS-UPDRS)-III Item #10 indicating observable gait impairment.
Exclusion Criteria for both groups include:
- diagnosis of any other neurological condition;
- significant cognitive impairment;
- unstable medical or concomitant illnesses or psychiatric conditions which, in the opinion of the investigators, would preclude successful participation;
- cardiac problems that interfere with ability to safely participate (i.e., uncontrolled congestive heart failure, myocardial infarction in past 6 months, complex cardiac arrhythmias, significant left ventricular dysfunction, dyspnea on exertion, chest pain or pressure, resting tachycardia (>100 beats/min); uncontrolled BP (resting systolic BP >160 mmHg or diastolic BP >100 mmHg));
- orthopedic problems in the lower extremities or spine that may limit walking (i.e., severe arthritis, spinal stenosis);
- contraindications for magnetic resonance imaging (e.g., metallic implants); or
- uncontrolled tremor or dyskinesia (while on PD medications if applicable).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Self cueing
People living with Parkinson disease and controls walking with self-generated rhythmic cues.
|
All participants (people with PD and age-matched controls) sing their song in their head and match their footfalls or finger tapping to the beat.
All participants (people with PD and age-matched controls) listen to their song and match their footfalls or finger tapping to the beat.
|
Active Comparator: External cueing
People living with Parkinson disease and controls walking to external rhythmic cues (i.e., music).
|
All participants (people with PD and age-matched controls) sing their song in their head and match their footfalls or finger tapping to the beat.
All participants (people with PD and age-matched controls) listen to their song and match their footfalls or finger tapping to the beat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stride Time Variability
Time Frame: Baseline
|
Measured with wearable sensors by APDM Wearable Technology
|
Baseline
|
Gait Speed
Time Frame: Baseline
|
Measured with wearable sensors by APDM Wearable Technology
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Oxygen Level Dependent Signal (BOLD) during movement
Time Frame: Baseline
|
Measure of the ratio of oxygenated to deoxygenated blood in the putamen, cortical motor areas, and cerebellum between individuals with PD and age-matched controls.
Higher values indicate more brain activity in the brain areas.
|
Baseline
|
Blood Oxygen Level Dependent Signal (BOLD) when listening to music vs. mentally singing
Time Frame: Baseline
|
Measure of the ratio of oxygenated to deoxygenated blood in the putamen and cortical motor areas for both groups.
Higher values indicate more brain activity in the brain areas during listening to music vs mentally singing.
|
Baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gammon Earhart, Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201908117
- 1R61AT010753-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Mentally singing
-
Washington University School of MedicineCompletedParkinson Disease | Parkinson Disease DementiaUnited States
-
Johns Hopkins UniversityNational Institute on Aging (NIA)CompletedMild Cognitive Impairment (MCI)United States
-
University of HelsinkiKarolinska University Hospital; Helsinki University Central HospitalCompletedNeurocognitive Dysfunction | Language Development
-
Nova Scotia Health AuthorityDalhousie UniversityCompletedMyocardial Infarction | Coronary Heart Disease | Ischemic Heart DiseaseCanada
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
University of SalzburgUniversity of Vienna; Paracelsus Medical University; Salzburger Landeskliniken; Universität Mozartuem SalzburgRecruiting
-
Royal Cornwall Hospitals TrustRecruitingChronic PainUnited Kingdom
-
Torbay and South Devon NHS Foundation TrustCompleted
-
Rabin Medical CenterUnknown
-
Hacettepe UniversityCompleted